Literature DB >> 9331975

The effects of Hange-shashin-to on the content of prostaglandin E2 and water absorption in the large intestine of rats.

Y Kase1, T Hayakawa, A Ishige, M Aburada, Y Komatsu.   

Abstract

The effects of Hange-shashin-to (TJ-14) were examined regarding the amount of prostaglandin E2 (PGE2) and the water absorbing capacity in the large intestine of rats. Repeated oral administration of TJ-14 at doses of 125 to 1000 mg/kg revealed a significant decrease in PGE2 content in the colonic mucosa and also the promotion of colonic water absorption in a dose dependent manner. However, there was no remarkable influence on the concentrations of aldosterone and electrolytes in the serum, even at 1000 mg/kg. From these results, it was considered that some of the anti-diarrheal effects of TJ-14 might be based on a repression of the increase in the amount of PGE2 as well as promotion of the water absorbing capacity of the large intestine. Moreover, it was also suggested that it is possible, by the application of TJ-14, to prevent the loss of water content caused by diarrhea.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9331975     DOI: 10.1248/bpb.20.954

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  15 in total

1.  Effect of Hangeshashinto on calprotectin expression in human oral epithelial cells.

Authors:  Yuka Hiroshima; Mika Bando; Yuji Inagaki; Reiko Kido; Masatoshi Kataoka; Toshihiko Nagata; Jun-Ichi Kido
Journal:  Odontology       Date:  2015-02-04       Impact factor: 2.634

Review 2.  Japanese herbal medicine in functional gastrointestinal disorders.

Authors:  H Suzuki; J M Inadomi; T Hibi
Journal:  Neurogastroenterol Motil       Date:  2009-03-25       Impact factor: 3.598

3.  Efficacy and safety of hangeshashinto for treatment of GERD refractory to proton pump inhibitors : Usual dose proton pump inhibitors plus hangeshashinto versus double-dose proton pump inhibitors: randomized, multicenter open label exploratory study.

Authors:  Toshihisa Takeuchi; Hitoshi Hongo; Tsuguhiro Kimura; Yuichi Kojima; Satoshi Harada; Kazuhiro Ota; Nozomi Takeuchi; Takao Noguchi; Takuya Inoue; Mitsuyuki Murano; Kazuhide Higuchi
Journal:  J Gastroenterol       Date:  2019-04-29       Impact factor: 7.527

Review 4.  Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.

Authors:  Umang Swami; Sanjay Goel; Sridhar Mani
Journal:  Curr Drug Targets       Date:  2013-06       Impact factor: 3.465

5.  A traditional Japanese medicine--Hangeshashinto (TJ-14)--alleviates chemoradiation-induced mucositis and improves rates of treatment completion.

Authors:  Taku Yamashita; Koji Araki; Masayuki Tomifuji; Daisuke Kamide; Yuya Tanaka; Akihiro Shiotani
Journal:  Support Care Cancer       Date:  2014-06-19       Impact factor: 3.603

6.  Effects of Banxia Xiexin Decoction () on Cisplatin-Induced Apoptosis of Human A549 Lung Cancer Cells.

Authors:  Ha-Rim Kim; Guem-San Lee; Mi-Seong Kim; Do-Gon Ryu; Hong-Seob So; Hyoung-Chul Moon; Young-Rae Lee; Sei-Hoon Yang; Kang-Beom Kwon
Journal:  Chin J Integr Med       Date:  2018-01-15       Impact factor: 1.978

7.  Preventive effect of kampo medicine (hangeshashin-to, TJ-14) plus minocycline against afatinib-induced diarrhea and skin rash in patients with non-small cell lung cancer.

Authors:  Masao Ichiki; Hiroshi Wataya; Kazuhiko Yamada; Nobuko Tsuruta; Hiroaki Takeoka; Yusuke Okayama; Jun Sasaki; Tomoaki Hoshino
Journal:  Onco Targets Ther       Date:  2017-10-24       Impact factor: 4.147

Review 8.  Kampo medicines for gastrointestinal tract disorders: a review of basic science and clinical evidence and their future application.

Authors:  Kazunari Tominaga; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2013-03-16       Impact factor: 7.527

9.  Significance of Kampo, traditional Japanese medicine, in supportive care of cancer patients.

Authors:  Jun-Ichi Yamakawa; Yoshiharu Motoo; Junji Moriya; Masao Ogawa; Hiroaki Uenishi; Sumiyo Akazawa; Toshiyuki Sasagawa; Matomo Nishio; Junji Kobayashi
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-19       Impact factor: 2.629

10.  Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis.

Authors:  Toru Aoyama; Kazuhiro Nishikawa; Nobuhiro Takiguchi; Kazuaki Tanabe; Motohiro Imano; Ryoji Fukushima; Junichi Sakamoto; Mari S Oba; Satoshi Morita; Toru Kono; Akira Tsuburaya
Journal:  Cancer Chemother Pharmacol       Date:  2014-03-21       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.